Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.
This report contains market size and forecasts of Rabeprazole in global, including the following market information:
Global Rabeprazole Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rabeprazole Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Rabeprazole companies in 2021 (%)
The global Rabeprazole market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rabeprazole include Eisai, Aytu Therapeutics, Avadel Pharmaceuticals, Zuche Pharmaceuticals, Cardinal Health, Jamp Pharma Corporation, Dominion Pharmacal, Apotex Corporation and Angita Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rabeprazole manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rabeprazole Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rabeprazole Market Segment Percentages, by Type, 2021 (%)
Tablet
Capsule
Global Rabeprazole Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rabeprazole Market Segment Percentages, by Application, 2021 (%)
Peptic Ulcer Disease
Gastroesophageal Reflux Disease
Others
Global Rabeprazole Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rabeprazole Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rabeprazole revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rabeprazole revenues share in global market, 2021 (%)
Key companies Rabeprazole sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Rabeprazole sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eisai
Aytu Therapeutics
Avadel Pharmaceuticals
Zuche Pharmaceuticals
Cardinal Health
Jamp Pharma Corporation
Dominion Pharmacal
Apotex Corporation
Angita Pharma
Mylan
Novartis
Livzon Pharmaceutical
C&O Pharmaceutical
Sinepharma
Aosaikang
Rundu Pharma
Luoxin Pharmacutical